Workflow
神州细胞: 神州细胞关于公司董事会完成换届选举暨聘任高级管理人员的公告

Group 1 - The company has completed the election of its third board of directors and appointed new senior management personnel [1][2] - The third board consists of 7 directors, including 4 non-independent directors and 3 independent directors, with a term of three years [1][2] - Xie Liangzhi has been elected as the chairman of the board, and the board has established specialized committees including the strategy committee, audit committee, and nomination and remuneration committee [2] Group 2 - The company has appointed Xie Liangzhi as the general manager, along with Yang Wang and Tang Liming as deputy general managers, and Ma Jie as the financial director [2][3] - The appointments of senior management have been approved by the board's nomination and remuneration committee, and the financial director's appointment was also approved by the audit committee [3][4] - The company has decided to abolish the supervisory board, transferring its powers to the audit committee of the board [4] Group 3 - Several directors have completed their terms and will no longer serve as non-independent or independent directors [4] - The company expresses gratitude for the contributions made by the outgoing directors and supervisors during their tenure [4]